Evidence map›Paper›PMID 36908429›Full record

ArticleFrontiers in public health2023

Time trends in mental health indicators in Germany's adult population before and during the COVID-19 pandemic.

Elvira Mauz, Lena Walther, Stephan Junker, Christina Kersjes, Stefan Damerow, Sophie Eicher, Heike Hölling, Stephan Müters, Diana Peitz, Susanne Schnitzer and 1 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Trial
  2. Article
  3. Trends in depressive symptoms in Germany's adult population 2008-2023.Social psychiatry and psychiatric epidemiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Elvira MauzDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Lena WaltherDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Stephan JunkerDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Christina KersjesDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Stefan DamerowDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Sophie EicherDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Heike HöllingDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Stephan MütersDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Diana PeitzDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Susanne SchnitzerInstitute of Medical Sociology and Rehabilitation Science, Charité-Universitätsmedizin, Berlin, Germany.
Julia ThomDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Times of crisis such as the COVID-19 pandemic are expected to compromise mental health. Despite a large number of studies, evidence on the development of mental health in general populations during the pandemic is inconclusive. One reason may be that representative data spanning the whole pandemic and allowing for comparisons to pre-pandemic data are scarce. Methods: We analyzed representative data from telephone surveys of Germany's adults. Three mental health indicators were observed in ~1,000 and later up to 3,000 randomly sampled participants monthly until June 2022: symptoms of depression (observed since April 2019, PHQ-2), symptoms of anxiety (GAD-2), and self-rated mental health (latter two observed since March 2021). We produced time series graphs including estimated three-month moving means and proportions of positive screens (PHQ/GAD-2 score ≥ 3) and reports of very good/excellent mental health, as well as smoothing curves. We also compared time periods between years. Analyses were stratified by sex, age, and level of education. Results: While mean depressive symptom scores declined from the first wave of the pandemic to summer 2020, they increased from October 2020 and remained consistently elevated throughout 2021 with another increase between 2021 and 2022. Correspondingly, the proportion of positive screens first decreased from 11.1% in spring/summer 2019 to 9.3% in the same period in 2020 and then rose to 13.1% in 2021 and to 16.9% in 2022. While depressive symptoms increased in all subgroups at different times, developments among women (earlier increase), the youngest (notable increase in 2021) and eldest adults, as well as the high level of education group (both latter groups: early, continuous increases) stand out. However, the social gradient in symptom levels between education groups remained unchanged. Symptoms of anxiety also increased while self-rated mental health decreased between 2021 and 2022. Conclusion: Elevated symptom levels and reduced self-rated mental health at the end of our observation period in June 2022 call for further continuous mental health surveillance. Mental healthcare needs of the population should be monitored closely. Findings should serve to inform policymakers and clinicians of ongoing dynamics to guide health promotion, prevention, and care.

Indexed as

COVID-19Mental HealthAdultFemaleGermanyHumansMalePandemicsTime Factorsanxiety symptomsCOVID-19 pandemicdepressive symptomsgeneral populationGermanymental health surveillancetime trends

Identifiers

PMID36908429
PMCPMC9995751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.